Mutual Fund Insights: BlackRock Healthcare Inv A Fund (MDHCX)

In-depth Analysis of BlackRock Healthcare Inv A Fund (MDHCX)

3 months 6 months 1 year 3 year 5 year

See BlackRock Healthcare Inv A Fund (MDHCX) performance details as of February 28, 2010

  

Last Trade: $5.83 on 3/19/2010, Change: +0.03 (0.52%)

  

Fund Manager - Robert C. Hodgson

Fund Manager Tenure: 12.2 years
Fundmojo Fund Grade: A (Score: 0.71)     (What does this score mean?)

Robert C. Hodgson has been a director of BlackRock, Inc. since 2006, was a director of MLIM from 1998 to 2006, was vice president of MLIM from 1997 to 1998 and was a portfolio manager in the equity management group of MLIM from 1997 to 2006.  Get more insights on Robert C. Hodgson

  

 What we like about BlackRock Healthcare Inv A Fund (MDHCX)

Data for BlackRock Healthcare Inv A Fund (MDHCX) as of February 28, 2010

• BlackRock Healthcare Inv A Fund (MDHCX) management has been with BlackRock Healthcare Inv A Fund for 12.2 years
• BlackRock Healthcare Inv A Fund (MDHCX) has good mid-term performance (3-year return 2.09% vs 0.87 % Health category average)
• BlackRock Healthcare Inv A Fund (MDHCX) has good Long-term performance (5-year return 5.84% vs 4.77 % Health category average)
• BlackRock Healthcare Inv A Fund (MDHCX) ratio of up-years vs down years is greater than 2
• BlackRock Healthcare Inv A Fund (MDHCX) has an annual stock turnover rate of 156.00% vs Health average of 169.11%. It is good that BlackRock Healthcare Inv A management does not trade extensively for its return.
• BlackRock Healthcare Inv A Fund (MDHCX) is less volatile than its peers as it has a 3-year Standard Deviation of 17.43, lower than category average of 18.82
• BlackRock Healthcare Inv A Fund (MDHCX) has a lower management fee than its Health average: 1.62% vs 1.98%

  

 What we are cautious about BlackRock Healthcare Inv A Fund (MDHCX)

Data for BlackRock Healthcare Inv A Fund (MDHCX) as of February 28, 2010

• BlackRock Healthcare Inv A Fund is a focused fund with 54.36% of the portfolio on top 10 securities. This tends to produce more volatility compared to a diversified fund. See fund top 10 holdings.
• BlackRock Healthcare Inv A Fund (MDHCX) has a less-than-ideal short-term performance (1-year return 38.46% vs 40.03 % Health category average)
• BlackRock Healthcare Inv A Fund (MDHCX) has a Morningstar rating of 3 and below
• BlackRock Healthcare Inv A Fund (MDHCX) carries a 5.25% load

See BlackRock Healthcare Inv A Fund (MDHCX) performance details as of February 28, 2010

  

  

Interested in other top mutual funds in similar Health category?

Below are some additional Health mutual funds generated out of our database

• Fidelity Select Pharmaceuticals (FPHAX)    [ Compare with BlackRock Healthcare Inv A Fund (MDHCX) ]
• See top fund managers for Health Category Funds
• Browse other funds in Health Category

  

BlackRock Healthcare Inv A Fund (MDHCX) Net Asset

Track net asset change of BlackRock Healthcare Inv A fund (MDHCX)

Date	Net Asset
02/2010	$340.23M
01/2010	$145.72M
11/2009	$143.63M

More historic net asset information on BlackRock Healthcare Inv A Fund (MDHCX)

  

BlackRock Healthcare Inv A Fund (MDHCX) Portfolio Allocation

Track portfolio allocation change of BlackRock Healthcare Inv A fund (MDHCX)

Date	Cash	Stock	Bond	Other
10/2009	8.16%	91.85%	0%	0%
07/2009	6.65%	93.35%	0%	0%
04/2009	7.5%	91.49%	0%	1.01%

Click here to see more historic asset allocation information on BlackRock Healthcare Inv A Fund (MDHCX)

  

Most Recent Top 10 Holdings in BlackRock Healthcare Inv A Fund (MDHCX)

Discover what BlackRock Healthcare Inv A Fund (MDHCX) manager is buying

31-Oct-09 WebMD Health Corp [9.3%] Blackrock Liquidity Series, Llc Money Market Series, 0.33% [8.04%] Celgene Corporation [6.27%] Gilead Sciences, Inc. [5.62%] Express Scripts, Inc. [4.82%] Genzyme Corporation [4.49%] MedcoHealth Solutions Inc Commo [4.26%] Masimo Corporation [3.99%] Baxter International Inc. Commo [3.82%] Vertex Pharmaceuticals Incorpor [3.75%]

31-Jul-09 Celgene Corporation [8.34%] Blackrock Liquidity Series, Llc Money Ma [7.11%] HLTH Corporation [6.67%] Gilead Sciences, Inc. [6.49%] Genzyme Corporation [4.84%] Express Scripts, Inc. [4.83%] MEDCOHEALTH SOLUTNS [3.97%] Vertex Pharmaceuticals Incorpor [3.84%] Masimo Corporation [3.8%] BAXTER INTL INC [3.73%]

30-Apr-09 Blackrock Liquidity Series, Llc Money Ma [8.14%] Gilead Sciences, Inc. [6.37%] Celgene Corporation [6.04%] HLTH Corporation [5.49%] Genzyme Corporation [5.18%] Express Scripts, Inc. [4.72%] Masimo Corporation [4.26%] Genoptix, Inc. [3.8%] [3.79%] Cephalon, Inc. [3.74%]

Click here for Stock Holding Change Map in BlackRock Healthcare Inv A Fund (MDHCX)

  

Related books and products to BlackRock Healthcare Inv A Fund (MDHCX)

  

Latest News on BlackRock Healthcare Inv A (MDHCX)

See what is happening with BlackRock Healthcare Inv A Fund (MDHCX)

Yahoo! Finance: RSS feed not found See more news on BlackRock Healthcare Inv A Fund (MDHCX)

 

Books and Resources

 

 

See more information on BlackRock Healthcare Inv A Fund (MDHCX)

• BlackRock Healthcare Inv A Fund Insights
• BlackRock Healthcare Inv A Fund Performance Data
• BlackRock Healthcare Inv A Fund News
• BlackRock Healthcare Inv A Fund Score Explaination
• BlackRock Healthcare Inv A Fund Manager Information
• Historic BlackRock Healthcare Inv A Fund Asset Allocation Report
• Historic BlackRock Healthcare Inv A Fund Top 10 Holding Tracking
• Historic BlackRock Healthcare Inv A Fund Asset Under Management Tracking